A detailed history of Mcdonald Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Mcdonald Partners LLC holds 21,017 shares of AMGN stock, worth $6.71 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
21,017
Previous 20,695 1.56%
Holding current value
$6.71 Million
Previous $5.88 Million 11.59%
% of portfolio
1.8%
Previous 1.65%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $84,605 - $102,817
322 Added 1.56%
21,017 $6.57 Million
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $16,132 - $19,473
-60 Reduced 0.29%
20,695 $5.88 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $118,133 - $133,268
-462 Reduced 2.18%
20,755 $5.98 Million
Q3 2023

Oct 30, 2023

SELL
$218.65 - $271.46 $29,517 - $36,647
-135 Reduced 0.63%
21,217 $5.7 Million
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $34,283 - $40,539
160 Added 0.76%
21,352 $4.74 Million
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $46,738 - $56,966
207 Added 0.99%
21,192 $5.12 Million
Q4 2022

Jan 18, 2023

SELL
$229.03 - $291.01 $5,954 - $7,566
-26 Reduced 0.12%
20,985 $0
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $18,181 - $20,505
81 Added 0.39%
21,011 $4.74 Million
Q2 2022

Jul 25, 2022

BUY
$230.71 - $256.74 $6,921 - $7,702
30 Added 0.14%
20,930 $5.09 Million
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $4.58 Million - $5.07 Million
20,886 Added 149185.7%
20,900 $5.05 Million
Q4 2021

Jan 31, 2022

SELL
$198.88 - $227.6 $4.1 Million - $4.69 Million
-20,600 Reduced 99.93%
14 $3,000
Q3 2021

Nov 24, 2021

SELL
$212.27 - $248.7 $33,538 - $39,294
-158 Reduced 0.76%
20,614 $4.38 Million
Q3 2021

Oct 28, 2021

BUY
$212.27 - $248.7 $113,564 - $133,054
535 Added 2.64%
20,772 $4.42 Million
Q2 2021

Nov 24, 2021

SELL
$233.58 - $259.14 $32,701 - $36,279
-140 Reduced 0.69%
20,237 $4.93 Million
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $24,525 - $27,209
105 Added 0.52%
20,377 $4.97 Million
Q1 2021

Nov 24, 2021

SELL
$221.91 - $258.6 $31,067 - $36,204
-140 Reduced 0.69%
20,272 $5.04 Million
Q1 2021

Apr 15, 2021

BUY
$221.91 - $258.6 $186,848 - $217,741
842 Added 4.3%
20,412 $5.08 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $4.23 Million - $5.04 Million
19,570 New
19,570 $4.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mcdonald Partners LLC Portfolio

Follow Mcdonald Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcdonald Partners LLC with notifications on news.